Review of Clinical Manifestations and Impact of Parasitic Protozoan Infections on Human Reproductive Health
Clinical Medicine Research
Volume 4, Issue 2, March 2015, Pages: 27-33
Received: Feb. 1, 2015; Accepted: Feb. 13, 2015; Published: Feb. 25, 2015
Views 2701      Downloads 129
Authors
Mulambalah Chrispinus Siteti, Department of Medical Microbiology & Parasitology, School of Medicine, College of Health Sciences, Moi University, Eldoret, Kenya
Siteti Darwin Injete, College of Health Sciences, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
Article Tools
Follow on us
Abstract
Parasitic protozoan infections that affect reproductive health are being increasingly recognized as a serious global health problem with impact on individual women and men, their families and communities. The infections can have severe consequences, including infertility, ectopic pregnancy, chronic pelvic pain, miscarriage, and increased risk of HIV transmission. Some affect both men and women, and can also be transmitted from mothers to children during pregnancy and childbirth. These infections affect more than just reproductive health, the resultant morbidity also affects the economic productivity and quality of life of many individual women and men, and consequently, of whole communities, regions and countries. The review intents to re-focus the attention of health professionals on this subject by shedding light on these unjustly neglected parasitoses commonly considered of low public health importance. Many of these parasitic infections have been forgotten and have become the neglected diseases often overlooked and rarely a high priority globally.
Keywords
Protozoal Infections, Reproductive Health, Pregnancy Outcomes, Infertility
To cite this article
Mulambalah Chrispinus Siteti, Siteti Darwin Injete, Review of Clinical Manifestations and Impact of Parasitic Protozoan Infections on Human Reproductive Health, Clinical Medicine Research. Vol. 4, No. 2, 2015, pp. 27-33. doi: 10.11648/j.cmr.20150402.11
References
[1]
WHO, 2008 http://www.who.int/topics/reproductive_health/en/].
[2]
Hall, Kelli Stidham, Caroline Moreau, and James Trussell. "Determinants Of And Disparities In Reproductive Health Service Use Among Adolescent And Young Adult Women In The United States, 2002-2008." American Journal of Public Health 102.2 (2012): 359-367.
[3]
Freedman LP, Isaacs SL. Human rights and reproductive choice. Studies in Family Planning, 1993, 24:18-30. (UN Programme of Action adopted at the International Conference on Population and Development, Cairo, 5-13 September 1994.
[4]
United Nations Population Fund (UNFPA), Male involvement in reproductive health, including family planning and sexual health, Technical Report, New York: UNFPA, 1995, No. 28.]
[5]
Faundes A, Hardy E, Pinotti JA. Commentary on women's reproductive health: means or end? International Journal of Gynecology and Obstetrics. 1989, (supp) 3:115-8.] (UN Programme of Action adopted at the International Conference on Population and Development, Cairo, 5-13 September 1994.
[6]
Carlton JM, Hirt RP, Silva JC, Delcher AL, Schatz M, Zhao Q, et al. Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis. Science. 2007; 315:207–212.
[7]
Fichorova RN, Trifonova RT, Gilbert RO, Costello CE, Hayes GR, Lucas JJ, et al. Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells. Infect Immun. 2006; 74:5773–5779.
[8]
Huang K-Y, Chien K-Y, Lin Y-C, Hsu W-M, Fong IK, Huang P-J, et al. A proteome reference map of Trichomonas vaginalis. Parasitol Res. 2009; 104:927–933.
[9]
Singh BN, Hayes GR, Lucas JJ, Sommer U, Viseux N, Mirgorodskaya E, et al. Structural details and composition of Trichomonas vaginalis lipophosphoglycan in relevance to the epithelial immune function. Glycoconj J. 2009; 26:3–17.
[10]
Zubácová Z, Cimburek Z, Tachezy J. Comparative analysis of trichomonad genome sizes and karyotypes. Mol Biochem Parasitol. 2008; 161:49–54.
[11]
Alderete JF, Kasmala L, Metcalfe E, Garza GE. Phenotypic variation and diversity among Trichomonas vaginalis isolates and correlation of phenotype with trichomonal virulence determinants. Infect Immun. 1986; 53:285–293.
[12]
McClelland RS. Trichomonas vaginalis infection: can we afford to do nothing? J Infect Dis.2008; 197:487–489.
[13]
Shafir SC, Sorvillo FJ, Smith L. Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans. Clin Microbiol Rev. 2009; 22:37–45.
[14]
Smith LM, Wang M, Zangwill K, Yeh S. Trichomonas vaginalis infection in a premature newborn. J Perinatol. 2002; 22:502–503.
[15]
Benchimol M, de Andrade Rosa I, da Silva Fontes R, Burla Dias AJ. Trichomonas adhere and phagocytose sperm cells: adhesion seems to be a prominent stage during interaction. Parasitol Res.2008; 102:597–604.
[16]
Sena AC, Miller WC, Hobbs MM, Schwebke JR, Leone PA, Swygard H, et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis. 2007; 44:13–22.
[17]
Caliendo AM, Jordan JA, Green AM, Ingersoll J, Diclemente RJ, Wingood GM. Real-time PCR improves detection of Trichomonas vaginalis infection compared with culture using self-collected vaginal swabs. Infect Dis Obstet Gynecol. 2005; 13:145–150.
[18]
Johnson LF, Coetzee DJ, Dorrington RE. Sentinel surveillance of sexually transmitted infections in South Africa: a review. Sex Transm Infect. 2005; 81:287–293.
[19]
Yadav M, Gupta I, Malla N. Kinetics of immunoglobulin G, M, A and IgG subclass responses in experimental intravaginal trichomoniasis: prominence of IgG1 response. Parasite Immunology.2005; 27:461–467.
[20]
Van Der Pol B, Williams JA, Orr DP, Batteiger BE, Fortenberry JD. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. J Infect Dis. 2005; 192:2039–2044.
[21]
Weinstock H, Berman S, Cates W., Jr Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004; 36:6–10.]
[22]
Simhan HN, Anderson BL, Krohn MA, Heine RP, Martinez de Tejada B, Landers DV, et al. Host immune consequences of asymptomatic Trichomonas vaginalis infection in pregnancy. Am J Obstet Gynecol. 2007; 196(59):e51–e55.
[23]
Al-Mohammed HI, Hussein EM. Comparison between secretory leukocytic protease inhibitor and reactive nitrogen intermediates levels in cervicovaginal secretions from symptomatic and asymptomatic trichomoniasis Egyptians patients. J Egypt Soc Parasitol. 2006; 36:763–777.
[24]
Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004; 363(9425):1965-76.
[25]
Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000; 30(12-13):1217-58.
[26]
Weiss LM, Dubey JP. Toxoplasmosis: A history of clinical observations. Int J Parasitol. 2009; 39(8):895-901.
[27]
Hill D, Dubey JP. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect. 2002; 8(10):634-40.
[28]
Sharifian M, Dalimi A, Kazemi B. Early diagnosis of toxoplasmosis by PCR method in the blood of experimentally infected rats. J Vet Res.2003; 58(4):323-327.
[29]
Zare F, Dalimi A, Ghaffarifar F. Detection of active Toxoplasma godii (RH strain) in the different body tissues of experimentally infected rats. Modares J Med Sci. 2006; 9(1):19-23.
[30]
Martinez-Garcia F, Regadera J, Mayer R, Sanchez S, Nistal M. Protozoan infections in the male genital tract. J Urol. 1996; 156 (2 Pt 1):340-9.
[31]
Nistal M, Santana A, Paniaqua R, Palacios J. Testicular toxoplasmosis in two men with the acquired immunodeficiency syndrome (AIDS). Arch Pathol Lab Med. 1986; 110(8):744-6.
[32]
Barreto F, Hering F, Dall'oglio MF, Martini Filho D, Campagnari JC, Srougi M. Testicular toxoplasmosis: a rare case of a testicular mass. Actas Urol Esp. 2008; 32(6):666-8.
[33]
De Paepe ME, Guerrieri C, Waxman M. Opportunistic infections of the testis in the acquired immunodeficiency syndrome. Mt Sinai J Med. 1990; 57(1):25-9.
[34]
Crider SR, Horstman WG, Massey GS. Toxoplasma orchitis: report of a case and a review of the literature. Am J Med. 1988; 85(3):421-4.
[35]
Haskell L, Fusco MJ, Ares L, Sublay B. Disseminated toxoplasmosis presenting as symptomatic orchitis and nephrotic syndrome. Am J Med Sci. 1989; 298(3):185-90.
[36]
Suresh Babu PS, Nagendra K, Navaz RS, Ravindranath HM. Congenital toxoplasmosis presenting as hypogonadotropic hypogonadism. Indian J Pediatr. 2007; 74(6):577-9.
[37]
Zhou YH, Lu YJ, Wang RB, Song LM, Shi F, Gao QF, et al. Survey of infection of Toxoplasma gondii in infertile couples in Suzhou countryside]. Zhonghua Nan Ke Xue. 2002; 8(5): 350-2.
[38]
Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. 3. Philadelphia: WB Saunders; 1990. pp. 89–195.
[39]
Ebbesen P. Placenta physiology. In: Ambroise-Thomas P, Petersen E, editors. Congenital toxoplasmosis: scientific background, clinical management and control. Paris: Springer-Verlag; 2000. pp. 27–35.
[40]
Remington JS, McLeod R, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. 4. Philadelphia: WB Saunders; 1995. pp. 140–267.
[41]
Chatterton JMW. Pregnancy. In: Ho-Yen DO, Joss AWL, editors. Human toxoplasmosis. Oxford: Oxford University Press; 1992. pp. 144–83.
[42]
Hayde M, Pollak A. Clinical picture: neonatal signs and symptoms. In: Ambroise-Thomas P, Petersen E, editors.Congenital toxoplasmosis: scientific background, clinical management and control. Paris: Springer-Verlag France; 2000. pp. 153–64.
[43]
Mandell GE, Bennett JE, Dolin R; Principles and Practice of Infectious Diseases. 5th edition,Philadelphia: Churchill Livingstone, 2000.
[44]
Antony SJ, Lopez-Po P. Genital amebiasis: historical perspective of an unusual disease presentation.Urology1999; 54:952–5.
[45]
Mhlanga BR, Lanoie LO, Norris HJ, et al. Amebiasis complicating carcinomas: a diagnostic dilemma. Am J Trop Med Hyg1992; 46:759–64.
[46]
Othman NH, Ismail AN. Endometrial amoebiasis. Eur J Obstet Gynecol Reprod Biol 1993; 52:135–7.
[47]
Calore EE, Calore NMP, Cavaliere MJ. Salpingitis due to Entamoeba histolytica. Braz J Infect Dis2002; 6:97–9.
[48]
Citronberg RJ, Semel JD. Severe vaginal infection with Entamoeba histolytica in a woman who recently returned from Mexico: case report and review. Clin Infect Dis1995; 20:700–715.
[49]
Mylius RE, Ten Seldam RE. Venereal infection by Entamoeba histolytica in a New Guinea couple. Tropical and Geographical Medicine1962; 14:20–6.
[50]
Nopdonrattakoon L Amoebiasis of the female genital tract: a case report. J Obstet Gynaecol Res. 1996 Jun; 22(3):235-8.
[51]
A.J. Veliath R. Bansal V. Sankaran, P. Rajaram, S. Parkash. Genital amebiasis . Internationa journal of Gynecology and Obstetrics June 1987 Volume 25, Issue 3, Pages 249-256 DOI: http://dx.doi.org/10.1016/0020-7292(87)90242-6.
[52]
Gupta Shipra, Nivedita Sarda, Seema Singhal, Anil Jain, Renu Arora .Endometrial Amoebiasis: A Rare Cause of Postmenopausal Vaginal Discharge. Sch J Med Case Rep 2014; 2(1):38-39.
[53]
Cabello I, Caraballo A, Millan Y. Leishmaniasis in the genital area. Rev Inst Med Trop Sao Paolo2002; 44:105–7.
[54]
Castro-Coto A, Hidalgo-Hidalgo H, Solano-Aguilar E, et al. Leishmaniasis en organos genitales. Med Cutan Ibero Lat Am1987; 15:145–50.
[55]
Blickstein I, Dgani R, Lifschitz-Mercer B. Cutaneous leishmaniasis of the vulva. Int J Gunaecol Obstet1993; 42:46–7.
[56]
Figueiro´ -Filho, E. A., Duarte, G. & El-Beitune, P., et al. (2004). Visceral Leishmaniasis (kala-azar) and Pregnancy. Infect Dis Obstet Gynecol, 12(1), 31–40.
[57]
Abrams ET, Meshnick SR. Abrams ET, Meshnick SR. Malaria during pregnancy in endemic areas: a lens for examining maternal-fetal conflict. Am J Hum Biol. 2009 Sep-Oct; 21(5):643-50. doi: 10.1002/ajhb.20919.
[58]
Breymann C, Iron Deficiency and Anaemia in Pregnancy: Modern Aspects of Diagnosis and Therapy. Blood Cells, Molecules, and Diseases. 2002; 29(3) Nov/Dec: 506–516.
[59]
Ezechi Oliver and Kalejaiye Olufunto (2012). Management of Anaemia in Pregnancy, Anemia, Dr. Donald Silverberg (Ed.), ISBN: 978-953-51-0138-3, InTech, Available from: http://www.intechopen.com/books/anemia/management-of-anaemia-in-pregnancy;
[60]
K. Marsh and R. W. Snow, “Malaria transmission and morbidity,” Parassitologia, vol. 41, no. 1–3, pp. 241–246, 1999.
[61]
Nicaise Tuikue Ndam and Philippe Deloron. Molecular Aspects of Plasmodium falciparum Infection during Pregnancy. Journal of Biomedicine and Biotechnology Volume 2007, Article ID 43785, 13 pages doi:10.1155/2007/43785.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186